浙江圣达生物药业股份有限公司向特定对象发行股票限售股上市流通公告

Core Viewpoint - The announcement details the upcoming public listing of restricted shares for Zhejiang Shenda Biological Pharmaceutical Co., Ltd., which will occur on December 25, 2025, involving a total of 17,840,666 shares [2][4][10]. Group 1: Stock Issuance Details - The stock type for this listing is non-publicly issued shares, with a total of 17,840,666 shares set for listing [2][3]. - The shares were issued to specific investors and are subject to a six-month transfer restriction from the issuance date [5][7]. Group 2: Changes in Share Capital - Following the issuance of restricted shares on June 25, 2025, the company's total share capital increased from 171,188,958 shares to 189,029,624 shares [6]. Group 3: Compliance and Commitments - The shareholders of the restricted shares have committed to not transferring their shares for six months post-issuance, and they have adhered to this commitment [7][9]. - The sponsor, CITIC Securities Co., Ltd., has confirmed that the application for the listing of restricted shares complies with relevant regulations and that the information disclosed is accurate and complete [8][9].